Advertisement
U.S. markets close in 1 hour 31 minutes

Relief Therapeutics Holding SA (RLFTF)

Other OTC - Other OTC Delayed Price. Currency in USD
1.8001-0.0499 (-2.70%)
As of 12:56PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.8500
Open1.8450
BidN/A x N/A
AskN/A x N/A
Day's Range1.8001 - 1.8900
52 Week Range0.0140 - 8.4000
Volume980
Avg. Volume3,670
Market Cap21.994M
Beta (5Y Monthly)-14.36
PE Ratio (TTM)N/A
EPS (TTM)-8.3400
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for RLFTF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • RELIEF THERAPEUTICS HOLDING AG
    Technical Assessment: Neutral in the Intermediate-TermWhile the Nasdaq continues to flirt with (finally) printing an all-time high (ATH), the last of which was in November 2021 at 16,057.44, the Nasdaq 100 (QQQ) has been in ATH territory since December 2023. And yes, the ETF has cycled into overbought (OB) territory on a daily and weekly basis and is close to cycling into OB territory on a monthly basis.
    Rating
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more